NO20002351L - Nye substituerte pyridin- eller piperidinforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem - Google Patents

Nye substituerte pyridin- eller piperidinforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem

Info

Publication number
NO20002351L
NO20002351L NO20002351A NO20002351A NO20002351L NO 20002351 L NO20002351 L NO 20002351L NO 20002351 A NO20002351 A NO 20002351A NO 20002351 A NO20002351 A NO 20002351A NO 20002351 L NO20002351 L NO 20002351L
Authority
NO
Norway
Prior art keywords
group
alkoxy
pyridine
piperidine
preparation
Prior art date
Application number
NO20002351A
Other languages
English (en)
Other versions
NO20002351D0 (no
NO317095B1 (no
Inventor
Otto Meth-Cohn
Chu-Yi Yu
Pierre Lestage
Marie-Cecile Lebrun
Daniel-Henri Caignard
Pierre Renard
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO20002351D0 publication Critical patent/NO20002351D0/no
Publication of NO20002351L publication Critical patent/NO20002351L/no
Publication of NO317095B1 publication Critical patent/NO317095B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/30—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom
    • C07D211/32—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by doubly bound oxygen or sulfur atoms or by two oxygen or sulfur atoms singly bound to the same carbon atom by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO20002351A 1999-05-05 2000-05-04 Nye substituerte pyridin- eller piperidinforbindelser, fremgangsmate ved deres fremstilling og farmasoytiske sammensetninger inneholdende dem NO317095B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9905690A FR2793245B1 (fr) 1999-05-05 1999-05-05 Nouveaux composes pyridiniques ou piperidiniques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (3)

Publication Number Publication Date
NO20002351D0 NO20002351D0 (no) 2000-05-04
NO20002351L true NO20002351L (no) 2000-11-06
NO317095B1 NO317095B1 (no) 2004-08-09

Family

ID=9545222

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002351A NO317095B1 (no) 1999-05-05 2000-05-04 Nye substituerte pyridin- eller piperidinforbindelser, fremgangsmate ved deres fremstilling og farmasoytiske sammensetninger inneholdende dem

Country Status (22)

Country Link
US (6) US6323220B1 (no)
EP (1) EP1050531B1 (no)
JP (2) JP3533361B2 (no)
KR (1) KR100472519B1 (no)
CN (1) CN100371326C (no)
AT (1) ATE282595T1 (no)
AU (1) AU764388B2 (no)
BR (1) BR0002287A (no)
CA (1) CA2308867C (no)
DE (1) DE60015844T2 (no)
DK (1) DK1050531T3 (no)
EA (1) EA003053B1 (no)
ES (1) ES2233302T3 (no)
FR (1) FR2793245B1 (no)
HU (1) HUP0001789A3 (no)
MX (1) MXPA00004343A (no)
NO (1) NO317095B1 (no)
NZ (1) NZ504338A (no)
PL (1) PL197661B1 (no)
PT (1) PT1050531E (no)
SI (1) SI1050531T1 (no)
ZA (1) ZA200002207B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7687513B1 (en) 2004-10-21 2010-03-30 University Of Notre Dame Du Lac Aminopyridinium ionic liquids
US7812098B2 (en) * 2006-03-31 2010-10-12 Depuy Products, Inc. Bearing material of medical implant having reduced wear rate and method for reducing wear rate
FR2905009A1 (fr) * 2006-08-18 2008-02-22 Servier Lab Methode de criblage de composes aux proprietes anti-amyloide
WO2009059260A1 (en) * 2007-11-02 2009-05-07 Yaupon Therapeutics, Inc. Use of lobeline epimers in the treatment of central nervous system diseases, pathologies, and drug abuse
WO2009061906A2 (en) * 2007-11-06 2009-05-14 Mayo Foundation For Medical Education And Research Treating protein misfolding diseases
EP2186419A1 (en) * 2008-11-13 2010-05-19 Tchibo GmbH NMP-containing extract, a method of its production and uses thereof
JPWO2010087315A1 (ja) * 2009-01-29 2012-08-02 株式会社林原生物化学研究所 抗アルツハイマー病剤
JPWO2010087313A1 (ja) * 2009-01-29 2012-08-02 株式会社林原生物化学研究所 神経突起伸展促進剤
EP2397139B1 (en) * 2009-01-29 2014-09-17 Hayashibara Co., Ltd. Anti-neurodegenerative disease agent
JP7319395B2 (ja) * 2019-06-14 2023-08-01 ディスアーム セラピューティクス， インコーポレイテッド Ｓａｒｍ１の阻害剤
USD1121577S1 (en) * 2023-05-01 2026-04-07 Wolfspeed, Inc. Power package

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3840523A (en) * 1973-04-25 1974-10-08 Richardson Merrell Inc Tricyclic arylalkylene lactamimides
US4082806A (en) 1975-12-18 1978-04-04 Wright State University Preparation of tetraketones
JPS5328177A (en) * 1976-08-25 1978-03-16 Teijin Ltd Optical active piperidine derivatives and their preparation
DE58902111D1 (de) * 1988-03-16 1992-10-01 Ciba Geigy Ag Thioverbindungen.
ES2051927T3 (es) * 1988-06-14 1994-07-01 Searle & Co 1,2-diariletilaminas para el tratamiento de daños neurotoxicos.
JP2522690B2 (ja) 1988-06-16 1996-08-07 富士写真フイルム株式会社 ハロゲン化銀カラ―写真感光材料
US5414005A (en) * 1993-10-28 1995-05-09 Dynagen, Inc. Methods and articles of manufacture for the treatment of nicotine withdrawal and as an aid in smoking cessation
GB9304919D0 (en) * 1993-03-10 1993-04-28 Celltech Ltd Chemical compounds
FR2756826B1 (fr) * 1996-12-05 1999-01-08 Adir Nouveaux derives tetrahydropyridiniques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US5830904A (en) * 1997-02-05 1998-11-03 University Of Kentucky Research Foundation Lobeline compounds as a treatment for psychostimulant abuse and withdrawal, and for eating disorders
US6087376A (en) * 1997-02-05 2000-07-11 University Of Kentucky Research Foundation Use of lobeline compounds in the treatment of central nervous system diseases and pathologies
AU5977598A (en) * 1997-02-07 1998-08-26 Synapse Pharmaceutical International, Inc. Pharmaceutical composition for treatment of synaptic dysfunction comprising an oxime
JPH10287634A (ja) * 1997-04-11 1998-10-27 Otsuka Pharmaceut Co Ltd ベンゼン誘導体
TW544448B (en) * 1997-07-11 2003-08-01 Novartis Ag Pyridine derivatives
ES2182203T3 (es) * 1997-10-31 2003-03-01 Hoffmann La Roche Derivados de d-prolina.
US6015824A (en) * 1998-02-10 2000-01-18 Hoffmann-La Roche Ag Pyrrolidine and piperidine derivatives and treatment of neurodegenerative disorders

Also Published As

Publication number Publication date
NO20002351D0 (no) 2000-05-04
AU764388B2 (en) 2003-08-14
PT1050531E (pt) 2005-03-31
KR100472519B1 (ko) 2005-03-07
US6638946B2 (en) 2003-10-28
AU3255200A (en) 2000-11-09
EA200000389A3 (ru) 2001-02-26
DK1050531T3 (da) 2005-03-21
ZA200002207B (en) 2000-11-14
MXPA00004343A (es) 2002-03-08
CA2308867C (fr) 2006-03-14
US6511992B2 (en) 2003-01-28
DE60015844D1 (de) 2004-12-23
PL197661B1 (pl) 2008-04-30
US6734196B2 (en) 2004-05-11
US20020035123A1 (en) 2002-03-21
CN1277192A (zh) 2000-12-20
CN100371326C (zh) 2008-02-27
PL339994A1 (en) 2000-11-06
US20030139408A1 (en) 2003-07-24
US20030181484A1 (en) 2003-09-25
HUP0001789A2 (en) 2001-03-28
BR0002287A (pt) 2001-01-02
ATE282595T1 (de) 2004-12-15
SI1050531T1 (en) 2005-04-30
DE60015844T2 (de) 2005-10-27
US20020040036A1 (en) 2002-04-04
NZ504338A (en) 2001-06-29
NO317095B1 (no) 2004-08-09
JP3533361B2 (ja) 2004-05-31
EP1050531B1 (fr) 2004-11-17
EA200000389A2 (ru) 2000-12-25
US20050004168A1 (en) 2005-01-06
ES2233302T3 (es) 2005-06-16
JP2002179652A (ja) 2002-06-26
US6323220B1 (en) 2001-11-27
CA2308867A1 (fr) 2000-11-05
HU0001789D0 (en) 2000-07-28
HUP0001789A3 (en) 2004-04-28
EP1050531A1 (fr) 2000-11-08
EA003053B1 (ru) 2002-12-26
FR2793245A1 (fr) 2000-11-10
KR20010020808A (ko) 2001-03-15
JP2000355579A (ja) 2000-12-26
FR2793245B1 (fr) 2002-10-11

Similar Documents

Publication Publication Date Title
US3773773A (en) N-alkyl-1,4-dihydropyridines and their production
RU2353616C2 (ru) Производные 2-пиридона в качестве ингибиторов эластазы нейтрофилов и их применение
CA2450922A1 (en) Piperidines for use as orexin receptor antagonists
DK131893A (da) 2-(Substitueret methyl)-4-(substitueret ethoxy)-5-(lavere alkyl)-pyridinforbindelser, farmaceutisk præparat, som indeholder sådanne samt anvendelse af en sådan forbindelse til fremstilling af et farmaceutisk præparat
KR870001196A (ko) 피리딘 화합물과 그의 제법 및 그를 함유하는 약학조성물
RU98101492A (ru) 4-арил-1-фенилалкил-1,2,3,6-тетрагидропиридины, способы их получения, промежуточные продукты, способы получения промежуточных продуктов, фармацевтическая композиция
RU2006101890A (ru) Производные тиазолилпиперидина в качестве ингибиторов мпб
RU98119523A (ru) Соединения пиперазина и пиперидина
NO20005166D0 (no) Nye benzotiofen-, benzofuran- og indolforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem
KR930005992A (ko) 루코트리엔 생합성 억제제
DE60223245D1 (de) Thiazol- und oxazolderivate, die sich für die behandlung von herzkreislauferkrankungen und ähnlichen erkrankungen eignen
CY1111075T1 (el) Φαρμακευτικες συνθεσεις που περιεχουν τα παραγωγα της 3-αμινο-αζετιδινης, τα νεα παραγωγα τους και η προετοιμασια τους
NO20002351D0 (no) Nye substituerte pyridin- eller piperidinforbindelser, fremgangsmÕte ved deres fremstilling og farmasøytiske sammensetninger inneholdende dem
FR2844270B1 (fr) Derives de la quinolyl propyl piperidine, leur procede et intermediaires de preparation et les compositions qui les contiennent
NO331165B1 (no) Derivater av dioksan-2-alkylkarbamater, fremgangsmate for fremstilling derav og anvendelse av de samme for fremstilling av medikamenter
KR920016422A (ko) N-페닐카바메이트 화합물, 이의 제조방법 및 유해한 유기체를 방제하기 위한 살균 조성물
RU98117457A (ru) Соединения производных окса- и тиа-диазола, способ их получения, фармацевтическая композиция и способы лечения
DK355784D0 (da) 2-(heterocyclylalkoxymethyl)-4-(aryl eller heteroaryl)-6-methyl-1,4-dihydropyridin-3,5- dicarboxylsyreestere og deres anvendelse til behandling af cardiovasculaere lidelser samt farmaceutiske praeparater indeholdende disse forbindelser
NO20082226L (no) 6-heteroarylpyridoindolonderivater, deres fremstilling og terapeutisk anvendelse derav
NO176176B (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive arylsulfonamider
KR910007928A (ko) 신규 벤조[1,8] 나프티리딘 유도체, 그의 제조 및 그를 함유하는 조성물
KR970704692A (ko) 류코트리엔 생합성의 억제제로서의 이미녹시카복실레이트 및 이의 유도체(Iminoxycarboxylates and derivatives as inhibitors of leukotriene biosynthesis)
KR880001593A (ko) 4-(아로일아미노)피페리딘부탄아미드 유도체
KR930004234A (ko) 메타노안트라센 화합물
NO20000373L (no) Nye cyano-indol serotinin-reopptaks-inhibitorforbindelser, fremgangsmÕte for deres fremstilling og farmasøytiske sammensetninger inneholdende dem